Innospec Inc.
NASDAQ:IOSPChemicals - Specialty
+$0.08 today
- Market cap
- $1.94B
- Beta
- 0.91
- P/E (TTM)
- 18.0
- EPS (TTM)
- $4.61
- Dividend yield
- 2.15%
Volume 0.23M
Average 0.24M
IOSP Total Current Liabilities
All obligations due within one year.
Innospec Inc.NASDAQ: IOSP
Total Current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total current liabilities rises 9.1% from a year ago
Total current liabilities stood at $368.1M at the end of Q2 FY2026, up 9.1% from a year earlier and up 9.9% from the prior quarter. Over 3 fiscal years it compounded at -3.9% a year.
Context
- Total current liabilities amounted to 19.9% of total assets at the end of Q2 FY2026, up 1.3 pp from a year earlier.
- Total current liabilities increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +9.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 360.1M USD
- Year-over-year change
- -3.0%
- 4-year CAGR
- +1.7%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 360.1M | -3.0% |
| FY2024 | 2024-12-31 | 371.4M | -0.0% |
| FY2023 | 2023-12-31 | 371.5M | -8.5% |
| FY2022 | 2022-12-31 | 405.8M | +20.6% |
| FY2021 | 2021-12-31 | 336.6M | — |
Total Current Liabilities vs competitors
How IOSP compares with its peers on the latest reported figures
- IOSP's Jun 2026 total current liabilities of $368.1M is the 8th highest of the 10 companies compared; the peer median is $510.76M.
- Its year-over-year change of +9.1% is the 8th highest of 10, against a peer median of +19.0%.
- Total current liabilities amounts to 19.9% of total assets for IOSP, versus a peer median of 14.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $2.84B | +19.0% | -6.6% | 18.4% | |
| Sep 2026 | $1.17B | +50.3% | -14.6% | 39.0% | |
| Jun 2026 | $1.14B | +53.4% | -4.7% | 28.6% | |
| Aug 2026 | $818.06M | +21.3% | +1.7% | 15.1% | |
| Jun 2026 | $510.76M | +27.0% | -0.4% | 14.1% | |
| Sep 2026 | $425.51M | +11.0% | +2.3% | 14.6% | |
| Jun 2026 | $424M | +1.0% | -8.5% | 9.3% | |
| Jun 2026 | $368.1M | +9.1% | -3.9% | 19.9% | |
| Sep 2026 | $112.76M | +14.4% | +4.9% | 11.1% | |
| Mar 2026 | $17.57M | -42.5% | -31.9% | 9.8% | |
| Peer median (excluding IOSP) | $510.76M | +19.0% | -4.7% | 14.6% | |
Competitors are the stored peer set for IOSP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 141.8M | 147.1M | 203.7M | 289.2M | 292.5M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 284.5M | 334.6M | 359.8M | 341.7M | 342.3M |
| Inventory | 277.6M | 373.1M | 300.1M | 301M | 329.3M |
| Other Current Assets | 400K | 400K | 600K | 600K | 7.3M |
| Total Current Assets | 728.1M | 872.6M | 885.7M | 956.6M | 1B |
| Property, Plant & Equipment (Net) | 249.8M | 266.2M | 313.4M | 314.5M | 338.8M |
| Goodwill | 364.3M | 358.8M | 399.3M | 382.5M | 399M |
| Intangible Assets | 57.5M | 45M | 57.3M | 65.4M | 67.7M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 6.4M | 5.9M | 10.4M | 9.4M | 13.6M |
| Other Non-current Assets | 164.8M | 55.2M | 41.3M | 6.3M | 8.7M |
| Total Non-current Assets | 842.8M | 731.1M | 821.7M | 778.1M | 827.8M |
| Total Assets | 1.57B | 1.6B | 1.71B | 1.73B | 1.83B |
| Account Payables | 148.7M | 165.3M | 163.6M | 163.8M | 174.7M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 3.7M | 18.4M | 2.6M | 3.1M | 13.1M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5.2M | 5.3M | 5.8M | 5M | 11.9M |
| Total Current Liabilities | 336.6M | 405.8M | 371.5M | 371.4M | 360.1M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 60.8M | 26.2M | 33.5M | 23.5M | 19.1M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 117.4M | 99.9M | 121.2M | 92.7M | 83.5M |
| Total Non-current Liabilities | 201.3M | 157.5M | 186.3M | 147.2M | 139.4M |
| Total Liabilities | 537.9M | 563.3M | 557.8M | 518.6M | 499.5M |
| Common Stock | 300K | 300K | 300K | 300K | 300K |
| Retained Earnings | 822.9M | 924.2M | 1.03B | 1.03B | 1.1B |
| Accumulated OCI | (46.9M) | (145.2M) | (148.1M) | (91M) | (34.7M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 600K | 2.4M | 2.5M | 4.9M | 6.8M |
| Total Equity | 1.03B | 1.04B | 1.15B | 1.22B | 1.33B |
| Total Debt | 35.6M | 45.3M | 45.2M | 44.9M | 52.7M |
| Net Debt | (106.2M) | (101.8M) | (158.5M) | (244.3M) | (239.8M) |
Innospec Inc.
NASDAQ:IOSP
Intrinsic Alpha fair value
Locked
Current Price
$78.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.